1014. Factors Associated with Switching from Tenofovir Diproxil Phosphate to a Tenofovir Alafenamide Based Regimen in a Cohort with Unrestricted Access to Care and Medications

BACKGROUND: Background- Tenofovir alafenamide (TAF) is associated with fewer renal and bone toxicities than tenofovir disoproxil phosphate (TDF). Hence, most experts suggest switching to TAF. We examined factors associated with switching to TAF in the US Military HIV Natural History Study (NHS), a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesan, Anuradha, Won, SeungHyun, Ewers, Evan C, Bradley, William, Schofield, Christina, Utz, Gregory, Colombo, Rhonda, Blaylock, Jason M, Lalani, Tahaniyat, Kronmann, Karl, Okulicz, Jason, Maves, Ryan C, Agan, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777286/
http://dx.doi.org/10.1093/ofid/ofaa439.1200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777286/
http://dx.doi.org/10.1093/ofid/ofaa439.1200

Ejemplares similares